Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Statistics

Total Valuation

STO:XBRANE has a market cap or net worth of SEK 126.13 million. The enterprise value is 97.84 million.

Market Cap	126.13M
Enterprise Value	97.84M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:XBRANE has 20.61 million shares outstanding. The number of shares has increased by 15,365.12% in one year.

Current Share Class	20.61M
Shares Outstanding	20.61M
Shares Change (YoY)	+15,365.12%
Shares Change (QoQ)	+2,154.60%
Owned by Insiders (%)	16.69%
Owned by Institutions (%)	5.08%
Float	15.03M

Valuation Ratios

The trailing PE ratio is 0.99.

PE Ratio	0.99
Forward PE	n/a
PS Ratio	0.83
PB Ratio	0.22
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.77
EV / Sales	0.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.12, with a Debt / Equity ratio of 0.10.

Current Ratio	7.12
Quick Ratio	1.88
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.80

Financial Efficiency

Return on equity (ROE) is -12.00% and return on invested capital (ROIC) is -5.21%.

Return on Equity (ROE)	-12.00%
Return on Assets (ROA)	-2.33%
Return on Invested Capital (ROIC)	-5.21%
Return on Capital Employed (ROCE)	-4.56%
Weighted Average Cost of Capital (WACC)	12.59%
Revenue Per Employee	5.86M
Profits Per Employee	4.89M
Employee Count	26
Asset Turnover	0.20
Inventory Turnover	0.28

Taxes

In the past 12 months, STO:XBRANE has paid 2.23 million in taxes.

Income Tax	2.23M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.25% in the last 52 weeks. The beta is 0.79, so STO:XBRANE's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-67.25%
50-Day Moving Average	10.56
200-Day Moving Average	22.82
Relative Strength Index (RSI)	22.38
Average Volume (20 Days)	67,344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:XBRANE had revenue of SEK 152.35 million and earned 127.24 million in profits. Earnings per share was 0.08.

Revenue	152.35M
Gross Profit	89.55M
Operating Income	-28.25M
Pretax Income	-43.93M
Net Income	127.24M
EBITDA	-13.65M
EBIT	-28.25M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 86.59 million in cash and 58.31 million in debt, with a net cash position of 28.28 million or 1.37 per share.

Cash & Cash Equivalents	86.59M
Total Debt	58.31M
Net Cash	28.28M
Net Cash Per Share	1.37
Equity (Book Value)	560.65M
Book Value Per Share	27.21
Working Capital	322.47M

Cash Flow

Operating Cash Flow	-250.69M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 58.77%, with operating and profit margins of -18.54% and 83.52%.

Gross Margin	58.77%
Operating Margin	-18.54%
Pretax Margin	-28.84%
Profit Margin	83.52%
EBITDA Margin	-8.96%
EBIT Margin	-18.54%
FCF Margin	n/a

Dividends & Yields

STO:XBRANE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15,365.12%
Shareholder Yield	-15,365.12%
Earnings Yield	100.89%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 17, 2025. It was a reverse split with a ratio of 0.008.

Last Split Date	Oct 17, 2025
Split Type	Reverse
Split Ratio	0.008

Scores

Altman Z-Score	n/a
Piotroski F-Score	3